Developer Of Sensitive Devices To Detect Diseases, Proteins Gets In-Q-Tel Funding

Biotech firm Quanterix raised $18.5 million in a funding round joined by CIA venture capital wing In-Q-Tel, the company announced. The firm is developing sensitive diagnostic technology that detects diseases and proteins at lower concentrations than other devices can.

French bioMérieux, which led the round, entered a licensing agreement with Quanterix and was granted exclusive rights to deploy its so-called Simoa technology in clinical laboratories. [...]